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ABSTRACT 
Objective: Aromatase is a key enzyme that plays a crucial role in the synthesis of estrogen and has a major effect in pathogenesis of 
estrogen-dependent disease, including breast cancer, endometrial cancer, and endometriosis. The abnormal over expression of aromatase can be 
inhibited by aromatase inhibitors. The objective of the present study is to evaluate the binding interaction of flavonoid compounds with cytochrome 
P450 enzyme aromatase, which is involved in the metabolism of estrogens and considered as a powerful target for treatment of estrogen-dependent 
breast cancers. 
Methods: To understand the mechanisms involved in the binding of flavonoid compounds and their interactions with the binding site of aromatase, 
molecular docking studies were carried using Autodock 4.2. 
Results: The docking results revealed that, benzoflavanones showed higher binding affinity compared to other class of compounds. The presence of 
hydrogen bond interaction and cation–π interaction contributed to their higher binding affinity. The flavonoid compounds with unsubstituted or 
less substituted rings showed higher binding affinity than those with substituted rings. The hydrogen bonding interactions were predominant in all 
the classes of compounds considered for the study and were found to be important for inhibition. The docking studies showed that the binding 
energies mainly depend on aromatic properties like cation–π and π–π interactions. These properties play a key role in determining the biological 
activity of flavonoid compounds. 
Conclusion: The present findings provided valuable information on the binding process of flavonoid compounds to the binding site of aromatase 
and revealed the structural requirement needed for binding. 
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INTRODUCTION 
Breast cancer is the most frequently diagnosed cancer and leading 
cause of death in females, worldwide. Many breast cancers are 
sensitive to the hormone estrogen, which causes breast cancer 
tumor to grow. The cancer of this type is called as HER2 positive 
breast cancer. HER2 refers to a gene that helps cells to grow, divide, 
and repair themselves. Mutation or damage in this gene or in the cell 
signalling pathway, leads to cancer [1]. Since 2008, breast cancer 
incidence has increased by more than 20%, while mortality has 
increased by 14%. It is also estimated that breast cancer is the most 
prevailing cancer worldwide [2]. Other than radiotherapy, 
chemotherapy many other surgical approaches are used for the 
treatment [3]. Estrogen plays a crucial role by binding to estrogen 
receptors, in promoting the proliferation of both the normal and 
neoplastic breast epithelium by inducing intracellular signalling 
cascades [4,5].  
Aromatase is the enzyme involved in estrogen biosynthesis, which 
can be inhibited for limiting the growth and development of 
estrogen dependent tumors. Human aromatase is the product of the 
CYP19A1 gene. This enzyme is located in the endoplasmic reticulum 
of the cell and its activity is regulated by tissue specific promoters 
that are in turn controlled by hormones, cytokines, and other factors. 
Inhibition of aromatase is an important approach for reducing 
growth-stimulatory effects of estrogens in estrogen-dependent 
breast cancer. Two primary approaches have been developed to 
reduce the growth stimulatory effects of estrogens in breast cancer 
like interfering with the ability of estrogen to bind to its receptor, 
and decreasing circulating levels of estrogen. Anti-estrogens 
(Tamoxifen) compete for binding to the estrogen receptors and 
reduce the number of receptors available for binding to endogenous 
estrogen [6]. Both steroidal and non-steroidal aromatase inhibitors 
have also shown clinical efficacy in the treatment of breast cancer. 
The potent and selective third- generation aromatase inhibitors, like 
anastrozole, letrozole, and exemestane were used in 
postmenopausal patients failing anti-estrogen therapy alone or 
multiple hormonal therapies. Use of an aromatase inhibitor as initial 
therapy or after treatment with tamoxifen is now recommended as 
adjuvant hormonal therapy for a postmenopausal woman with 
hormone-dependent breast cancer [7].  
As like anti-estrogen, steroidal and non-steroidal aromatase 
inhibitors, flavonoids also play a major role in aromatase inhibition. 
Flavonoids are a group of phytochemicals produced by various 
plants in high qualities. Based on their skeleton, flavonoids classified 
to flavans, flavones, flavanones, isoflavones, isoflavanones, 
anthocyanidines, chalcones, flavanoligans and flavonols, each 
possessing the benzopyranone ring system as the common chemical 
scaffold. Flavonoids exert anti-inflammatory, analgesic, anti-allergic 
effects, apoptotic, estrogenic and anti-estrogenic properties. 
Flavonoids interacts with CYP450 enzymes in atleast three way: by 
inducing biosynthesis of several CYPs, by modulating the enzymatic 
biosynthesis of CYPs (inhibited or stimulated) and the last is the 
metabolism of flavonoids by several CYPs in turn. They poses both 
induction of CYP mediated carcinogenesis as well as inhibition of the 
same by scavenging free radicals formed by CYP catalysed reactions. 
As aromatase inhibitors, flavonoids has structure resembling the 
estrogen skeletons, they bind to the estrogen receptor in turn 
modulates its activity [8]. Flavones have been demonstrated to be 
competitive inhibitors of aromatase with respect to the androgen 
substrate, with Ki values at low micromolar concentrations. The 
binding characteristics and the structural requirement necessary for 
the inhibition of human aromatase by flavone and isoflavone 
phytoestrogens were obtained using computer modelling and 
confirmed by site–directed mutagenesis. It was found that these 
compounds bind to the active site of aromatase in an orientation in 
which their A-ring and C-ring mimic rings D and C of the androgen 
substrate, respectively [9]. Initial attempts to study the aromatase 
and its inhibitors interaction have been relied on homology derived 
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models. At present there are crystal structures available for human 
placental aromatase. Thus the availability of the structural details of 
aromatase active sites help to understand the binding nature of 
aromatase inhibitors and also to evaluate key residues needed for 
binding. Molecular docking is one of the foremost approaches to 
understand the binding interactions that govern the enzyme 
inhibition [3]. In this study, docking calculations were performed to 
elucidate the binding modes of all flavonoid compounds with 
aromatase.  The crystal structure of the human placental aromatase 
(PDB ID: 3EQM) solved by Gosh et al, 2009 [10] was considered for 
docking studies. The tertiary structure consists of 12 major helices 
and 10 strands distributed into one major and 3 minor sheet, and 
follow the characteristic CYP450 fold.  
A striking feature of the tertiary aromatase structure is that long 
loops interconnect well–defined secondary structure elements, was 
observed with other P450 structures. The active site of aromatase is 
the distal cavity of the heme–binding pocket and the Heme Fe is the 
reaction centre of the enzyme. The amino acid Asp309 is proposed 
to be a catalytically important residue. The residue Asp309 appears 
to be involved not only in catalysis but also in substrate binding. 
Several flavonoid compounds were synthesized and tested for 
aromatase inhibitor [11-16]. These structural features play an 
important role in determining the binding mode of several drugs 
including aromatase inhibitors [17].  
MATERIALS AND METHODS 
Preparation of the protein and Ligand Structures 
The three dimensional X–ray structure of aromatase complexed with 
androstenedione (ASD), was obtained from Brookhaven Protein 
Data Bank (PDB ID: 3EQM). The crystal structure was refined by 
removing water molecules and the cofactor, phosphate ion. The 
heme was retained in the binding site. Hydrogen atoms were added 
and electronic charges were assigned to the protein atoms using 
kollman united atoms force field by using AutoDockTools–1.5.6 [18].  
To understand the binding nature of the ASD, the ASD was removed 
and redocked into the binding site of aromatase. The docking 
calculations were carried out using both the Genetic Algorithm and 
Lamarckian Genetic Algorithm.  
The docked conformations obtained using LGA could able to 
reproduce the binding modes reported in the crystal structure 
solved by Ghosh et al. In this paper, the Lamarckian Genetic 
Algorithm (LGA) was used to explore the binding conformational 
landscape of flavonoid compounds. The flavonoid compounds 
considered for the present study are given in the Scheme 1 [11-16]. 
The compounds were geometrically optimized using AM1 
Hamiltonian in MOPAC software package [19]. The gasteiger partial 
atomic charges were added and all possible flexible torsion angles of 
the ligand was defined by using AUTOTORS. The structures were 
saved in a PDBQT format for AutoDock calculations. 
Docking Studies 
Docking calculations were performed to predict the binding affinity 
between the aromatase and flavonoid compounds using AutoDock 
4.2 [20]. AutoDock requires pre–calculated grid maps, one for each 
atom type present in the ligand being docked. These maps were 
calculated by using the auxiliary program AutoGrid. The compounds 
treated as flexible molecules were allowed to move in the six spatial 
degrees of freedom for orientation and torsional degrees of freedom 
within the grid box. Lennard–Jones parameters 12–10 and 12–6, 
implemented with the program, were used for modeling H–bonds 
and van der Waals interactions, respectively.  
AutoDock uses a semi empirical free energy force field to evaluate 
conformations during docking simulations. The energy functions 
define what contributes to the energy of the molecule, like bond 
stretching, bending etc., so that energy of the molecule can be 
calculated for any particular conformation. The force field evaluates 
binding in two steps. In the first step, the intramolecular energetics 
is estimated for the transition from unbound states to the 
conformation of the ligand and protein in the bound state. The 
second step then evaluates the intermolecular energetics of 
combining the ligand and protein in their bound conformation. 
∆G = ∆Gvdw + ∆Ghbond + ∆Gelec +∆Gtor+ ∆Gdesolv 
First three terms are for van der Waal’s, hydrogen bonding, 
electrostatics respectively. The term ∆Gtor is for rotation and 
translation and ∆Gdesolv is for desolvation upon binding and the 
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Scheme 1 (continued): The analogs of flavonoid compounds are shown. 
 
RESULTS AND DISCUSSIONS 
The binding energy and their corresponding intermolecular energy, 
electrostatic energy, internal energy and torsional energy for each 
class of flavonoids with aromatase are given in Table 1. All the 
energies are reported in kcal/mol. Figure 1 shows the lowest 
binding energy conformation of each flavonoid class. Their 
interacting residues in the binding site of aromatase are represented 
in elemental coloured ball and stick model. The maroon colour 
dashed lines between the atoms represent the hydrogen bonds. 
 
Table 1: Molecular docking energies of flavonoids with aromatase are shown. 
Compounds ∆GBE ∆Gintermol ∆Gelect ∆Ginternal ∆Gtor 
BF1 –7.24 –7.54 –0.05 –0.32 0.30 
BF2 –7.56 –7.86 –0.19 –0.34 0.30 
BF3 –7.16 –7.46 –0.02 –0.33 0.30 
BF4 –7.40 –7.99 –0.16 –0.26 0.60 
BF5 –6.93 –7.52 –0.24 –0.27 0.60 
TF1 –5.99 –6.89 –0.16 –0.63 0.89 
TF2 –6.53 –7.43 –0.31 –0.42 0.89 
TF3 –6.64 –7.54 –0.17 –0.60 0.89 
IF1 –5.97 –6.86 –0.23 –0.22 0.89 
IF2 –6.13 –7.02 –0.21 –0.46 0.89 
PF1 –7.02 –7.62 –0.14 –0.72 0.60 
 PF2 –5.45 –6.34 0.02 –0.82 0.89 
PF3 –6.97 –7.57 –0.07 –0.61 0.60 
PF4 –7.04 –7.94 –0.12 –0.72 0.89 
HF1 –5.63 –6.82 –0.21 –0.25 1.19 
HF2 –5.88 –7.37 –0.24 –1.20 1.49 
HF3 –6.13 –7.62 –0.28 –1.21 1.49 
HF4 –5.70 –7.78 –0.78 –1.42 2.09 
HF5 –5.30 –6.50 –0.50 –0.31 1.19 
HF6 –6.75 –7.94 –0.51 –0.80 1.19 
HF7 –6.48 –7.98 –0.78 –0.94 1.49 
HF8 –5.96 –6.86 –0.24 –0.66 0.89 
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Docking analysis of Benzoflavanones 
The benzoflavanones (BF) [11] binding energy were in the range ~ –7.0 
kcal/mol. They possessed lowest binding energy compared to all other 
class of compounds considered for study. The common binding site 
residues interacting with BF were Met374, Ser478, Ala306, 
Asp309, Thr310 and Arg115. Interestingly BF1, BF3 and BF5 
showed cation–π interactions between Arg115 and the benzo ring 
of the flavanone.  
Even though the above compounds exhibited cation–π interactions, 
comparing to BF3 and BF5 the binding energy was low for BF1 
compound, which may be due to the unsubstituted benzo group in 
BF1. In BF2 and BF4 there are hydroxy (–OH) and cyano (–CN) 
groups present at the meta (C3׳) positions of the B-ring.  
Presence of electron-withdrawing groups like cyano and electron-
donating groups such as the hydroxyl on B-ring, increased the 
inhibitory effect can be seen in BF2 and BF4. Among all the five 
compounds only the BF4 hydroxyl group which is in the meta 
position in B-ring showed hydrogen bond with Met374 (Met374 
NH···OH). In benzoflavanones, ∆Gelect, ∆G internal interactions 
contributed very less to the binding energy and the significant 
contribution to the binding energy was due to ∆Gintermol energy, 
which is the sum of vdW, hydrogen bonding and desolvation, and 
torsional energies.  
The torsional energy was almost the same for BF1–3 which was 
~0.3 kcal/mol and BF4–5 showed torsional energy of ~0.6 
kcal/mol. Torsion angles within a molecule are defined by four 
atoms connected by three bonds. BF1–3 had one rotatable bond and 
BF4–5 had two rotatable bonds, therefore, higher torsional energy 
than BF1–3. 
Docking analysis of Triazolylflavans 
Binding energy of Triazolylflavan (TF) [12] was in the range ~–6.0 
kcal/mol and among them the lowest binding energy was shown by 
TF3. The common residues in the binding site interacting with TF 
were Ser478, Thr310, Asp309, Trp224, Leu477, Met374 and Ile133. 
The oxygen of oxymethyl groups in TF2 and TF3 showed hydrogen 
bond with the hydrogen ion of hydroxyl group in Ser478 (Ser478-
OH···OCH3) residue at a distance of 1.745 Å and 1.778 Å respectively. 
Though TF2 showed a stronger hydrogen bond than TF3, its 
binding affinity was less than TF3. TF1 exhibited a π–π 
interaction between the C-ring of flavan and imidazo group of 
tryptophan (Trp224) residue but its binding energy was very 
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Fig. 1: Flavonoid compounds having lowest binding energy with aromatase are shown. 
Table 1 (Continued): Molecular docking energies of flavonoids with aromatase are shown. 
Compounds ∆GBE ∆Gintermol ∆Gelect ∆Ginternal ∆Gtor 
 HF9 –5.85 –7.35 –0.46 –0.85 1.49 
HF10 –6.77 –7.07 –0.18 –0.25 0.30 
HF11 –7.03 –7.63 –0.10 –0.26 0.60 
HF12 –7.02 –7.62 –0.25 –0.27 0.60 
HF13 –6.80 –7.10 –0.07 –0.27 0.30 
HF14 –7.15 –7.45 –0.05 –0.30 0.30 
HF15 –6.55 –7.15 –0.18 –0.21 0.60 
HF16 –6.53 –7.43 –0.12 –0.81 0.89 
HF17 –6.43 –7.33 –0.31 –0.18 0.89 
HF18 –6.47 –7.66 –0.48 –0.78 1.19 
HF19 –6.32 –6.92 –0.09 –0.30 0.60 
HF20 –6.21 –7.10 –0.31 –0.81 0.89 
HF21 –6.06 –7.26 –0.16 –1.29 1.19 
HF22 –6.16 –7.95 –0.90 –1.64 1.79 
HF23 –6.30 –6.90 –0.13 –0.21 0.60 
HF24 –6.17 –7.06 –0.36 –0.17 0.89 
HF25 –6.47 –7.07 –0.22 –0.82 0.60 
HF26 –5.27 –6.47 –0.37 –0.88 1.19 
 
As in benzoflavonones, the contribution of ∆Gelect, ∆Ginternal 
interactions were very less to binding energy in the triazolylflavans, 
and energy contribution was due to the ∆G intermol energy. The 
torsional energy for TF1–3 was same of ~0.9 kcal/mol as they had 
three rotatable bonds. 
Docking analysis of imidazolylflavans 
The imidazolylflavans (IF) [13] showed binding energy in the range 
~–6.0 kcal/mol. The lowest energy was exhibited by IF2 which has a 
7-oxymethyl  substitution. The most common residues in the binding 
site that interact with IF were Ser478, Thr310, Ala306, Asp309, 
Phe221, Leu477, Met374 and Ile133. In IF2, the oxygen atom of the 
7–oxymethyl group showed hydrogen bond with hydroxyl hydrogen 
of Ser478 (Ser478 OH···OCH 3) at a distance of 1.725Å whereas the 
hydroxyl group of IF1 showed no hydrogen bond with the nearby 
residues.  
This could be one of the reasons why IF1 had higher binding energy 
or lower binding affinity than IF2. In imidazolyl flavans, ∆G elect, 
∆Ginternal interactions contributed less to the binding energy and the 
significant contribution to the binding energy was due to ∆G intermol 
energy. The compounds IF1 and IF2 had three rotatable bonds and a 
same torsional energy of ~0.9 kcal/mol. 
Docking analysis of pyridinyl-substituted flavanones 
The Pyridinyl-substituted flavanones (PF) [14] showed binding 
energies between –7.0 and –6.0 kcal/mol and of which the lowest 
energy was shown by PF4. The binding site residues that commonly 
interacted with PF were Ser478, Thr310, Ala306, Trp224, Leu477, 
Met374 and Ile133. The hydrogen bond with the hydroxyl group of 
Ser478 (Ser478 OH···N) were with the nitrogen of the pyridinyl ring 
in PF3 and PF4 at a distance of 2.097Å and 2.024Å respectively.  
The oxygen of 7-oxymethyl group of PF4 also made hydrogen bond 
with the amino hydrogen of Met374 (Met374 HN···OCH 3) at a 
distance of 1.974Å. This could be one of the reasons for the lowest 
binding energy or highest binding affinity of PF4 compared to PF1–
3 as the 7-methoxy group of PF4 acts as hydrogen bond acceptor 
and interacts well with amino acid residues of aromatase.   
The benzo group of all the compounds from PF1–4 showed cation–π 
interactions with the Fe of heme, and pyridinyl ring of PF2 showed 
cation–π interaction with Arg115. From the docking results obtained 
for PF1–4, Z-isomer of oxymethyl pyridinyl substituted flavanones 
and E-isomer of unsubstituted pyridinyl flavanones showed lower 
binding energy or higher binding affinity as the restrained 
configuration of E–isomer could bring the pyridine nitrogen closer 
to heme Fe for a possible interaction.  
In pyridinyl-substituted flavanones, the contribution of ∆Gelect, 
∆Ginternal interactions was less to the binding energy and the 
significant contribution to the binding energy was due to ∆G intermol 
energy. PF1 and PF3 had two rotatable bonds and the same 
torsional energy of ~0.5 kcal/mol. PF2 and PF4 had three rotatable 
bonds with a torsional energy of ~0.9kcal/mol. 
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Docking analysis of hydroxy flavones 
Hydroxyflavones (HF) [15] showed binding energies between –7.0 
and –5.0 kcal/mol and the lowest binding energy was shown by 
HF14. The residues of binding site interacting with the HF were 
Ser478, Thr310, Ala306, Phe221, Leu372, Arg115, Trp224, Met374 
and Ile133. HF14, which has the lowest binding energy among all 
the hydroxyflavones, showed a cation–π interaction between the B-
ring and Arg115. HF14 was the only unsubstituted flavone in that 
class and studies have shown that unsubstituted flavones showed 
higher aromatase inhibiting activity as they can correctly fit in the 
binding site. Out of the 26 hydroxyflavones taken for the study, 20 of 
them showed cation–π interactions with Fe of heme. HF11 and 
HF12 followed HF14 in having low binding energies, where, HF11 
showed a cation–π interaction between B-ring and Fe of heme and 
Arg115, and hydroxyl oxygen of its B–ring showed a hydrogen bond 
with amine hydrogen of Met374 (Met374 NH···OH) at a distance of 
1.797Å. HF12 also showed cation–π interaction with Arg115 and a 
hydrogen bond between hydroxyl oxygen of 7,8-benzo ring and 
amine hydrogen of Met374 (Met374 NH···OH ) at a distance of 
1.634Å. In addition, studies have shown that presence of hydroxyl 
group at the C7 position increases inhibitory potency as they serve as 
hydrogen bond acceptor to interact with the nearby residues, as 
seen in HF11 and HF12.  
As mentioned in the literature isoflavones showed less binding 
affinity and less inhibition of aromatase than flavanones and 
flavones. HF12 formed a stronger hydrogen bond than the rest of 
the hydroxyflavones and therefore, is lower binding energy. HF26 is 
an isoflavone and showed the highest binding energy –5.27 
kcal/mol. It also showed a hydrogen bond between C7 hydroxyl 
hydrogen and hydroxyl oxygen of Thr310 (Thr310 HO···HO) at a 
distance of 2.102Å, which is a weak interaction, compared to that 
seen in HF12 and HF14. Hydroxyl substituted derivatives showed 
lower binding energies than methoxy derivatives as the hydroxyl 
groups showed the ability to form hydrogen bonds. In 
hydroxyflavones, ∆Gelect, ∆Ginternal interactions contributed less to the 
binding energy and the significant contribution to the binding 
energy was due to ∆Gintermol energy. The torsional energy ranges from 
0.30–2.09 kcal/mol. HF4 had eight rotatable bonds, therefore, 
showed the highest torsional energy 2.09 kcal/mol.  
Docking analysis of pyridylmethyl thio isoflavones 
The binding energies obtained for TIF [16] ranged between –6.0 and 
2.0 kcal/mol. The lowest energy was exhibited by TIF1. These 
compounds were found to bind near a binding site other than the 
experimentally identified binding site. Therefore, a search was 
conducted in the Q-site finder [21] to identify the possible binding 
sites in the aromatase. Q-site finder showed ten binding sites in 
aromatase and the thio compounds were found to bind near site 4, 
which is located away from the experimentally identified binding 
site. The common residues that interact with thio compounds were 
Tyr424, Phe427, Phe430, Lys 448, Met444 and Val 445. Though 
these compounds were bound at a different site, they displayed 
significant hydrogen bond and cation–π interactions and high 
torsional energies. The torsional energies obtained were 2.09 and 
2.39 kcal/mol. The compound with the lowest binding energy (TIF1) 
showed there hydrogen bond interactions, two π–π interaction 
between and one cation–π interactions. A hydrogen bond was 
formed between amine hydrogen of Gln428 and nitrogen of the 
pyridine ring of TIF1 (Gln428 NH···N) at a distance of 1.962Å. The 
other hydrogen bonds were formed between hydroxyl hydrogen of 
Tyr361 and carbonyl oxygen of C-ring of flavone (Tyr361 OH···OC) at 
a distance of 2.233Å and amine hydrogen of Lys448 and oxygen of 
the nitrobenzene ring of TIF1 (Lys448 NH2···O2N) at a distance of 
1.809Å. This could be one of the reasons why TIF1 showed higher 
activity than the other compounds of the same class. 
CONCLUSION 
In the present study, the binding and interactions of flavonoid 
compounds (flavans, flavanones, isoflavones and flavones) with 
aromatase have been studied using molecular docking calculations. 
Most of the compounds have shown significant binding interactions 
with the aromatase. It was observed that the benzo ring is an 
important but not the only structural requirement to evoke 
aromatase inhibition. The hydrogen bond interactions and cation–π 
interactions also contributed to the strong binding of these 
compounds to the binding site of aromatase. An increase in binding 
energy was observed when there is substitution at C7 and C8 position 
of A-ring of the flavanone. Compounds with unsubstituted or less 
substituted rings showed higher activity than substituted rings.  
This is possibly because the binding cavity was not large enough to 
accommodate bulky substituted compounds without steric clashes. 
Hydrogen bonding interactions were predominant in all the classes 
of compounds taken for study and were found to be important for 
inhibition. Among the compounds considered for the study, BF4, 
TF2, TF3, IF2, PF3, PF4, HF1–9, HF11–12 and HF15–26 showed 
hydrogen bonding with some of the residues in the binding site of 
aromatase. BF1, BF3, BF5, PF1–4, HF1–5, HF7, HF8, HF10–17, 
HF19 and HF21–26 showed cation–π interaction. Amino acids 
Thr310, Met374 and Ser478 are the common residues that interact 
with the flavonoid compounds BF, TF, PF, IF and HF. The amino acid 
Asp309 which is involved in ASD substrate binding also plays a key 
role in binding of flavonoid compounds BF, TF and IF. Interestingly 
the thio isoflavones, which had an extended hydrocarbon chain 
showed decreased activity and those compounds, were found to 
bind at a different binding site in the enzyme rather than the 
experimentally identified binding site. The decrease in activity 
compared to the other class of compounds may be due to 
unfavourable interactions with the binding site residues. This study 
provides a detailed insight into binding of the flavonoid compounds, 
to the aromatase.  
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